GAIN THERAPEUTICS INC's ticker is GANX and the CUSIP is 36269B105. A total of 22 filers reported holding GAIN THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,710,732 | +95954.6% | 546,560 | 0.0% | 0.12% | -6.3% |
| Q3 2022 | $1,781 | -9.5% | 546,560 | 0.0% | 0.13% | -17.6% |
| Q2 2022 | $1,967 | -12.0% | 546,560 | 0.0% | 0.15% | +7.7% |
| Q1 2022 | $2,236 | -24.7% | 546,560 | 0.0% | 0.14% | -16.5% |
| Q4 2021 | $2,968 | -27.1% | 546,560 | 0.0% | 0.17% | -37.7% |
| Q3 2021 | $4,069 | -25.6% | 546,560 | 0.0% | 0.27% | -20.4% |
| Q2 2021 | $5,466 | -33.0% | 546,560 | 0.0% | 0.34% | -39.6% |
| Q1 2021 | $8,155 | – | 546,560 | – | 0.57% | – |
Download | ||||||